Preclinical development of ADCT-211, a novel pyrrolobenzodiazepine dimer-based antibody-drug conjugate targeting solid tumors expressing IL13RA2

ADCT-211 - ADC Therapeutics

SG 2000 - AstraZeneca

https://www.abstractsonline.com/pp8/#!/10828/presentation/9532

Francesca Zammarchi; Karin Havenith; Ben Leatherdale; Britanny Roberts; Lara Montolio; Afroze Patel; Narinder Janghra; Pedro Alves; Kristina Zaitseva; Cecile Oblette; Ian Kirby; Lolke de Haan; Patrick H van Berkel

Mar 14, 2023